rMal-d-1 derivative (Medical University of Vienna)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamerMal-d-1 derivative (Medical University of Vienna)
Drug Alias NamerMal-d-1 derivative (Medical University of Vienna)apple allergen immunotherapy (Medical University of Vienna)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedical University Of Vienna
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A